WELL
Welltower Inc.
NYSE · Real Estate · REIT - Healthcare Facilities · US
$236.17
−2.05%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 12.6B | 10.7B | 7.9B | 6.5B | 5.8B |
| Cost of Revenue | 7.7B | 6.5B | 4.8B | 3.9B | 3.6B |
| Gross Profit | 4.9B | 4.2B | 3.0B | 2.5B | 2.2B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 1.8B | 1.7B | 235.5M | 179.1M | 150.4M |
| General & Admin Expense | 1.8B | 1.7B | 235.5M | 179.1M | 150.4M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 2.5B | 2.1B | 1.6B | 1.4B | 1.3B |
| Total Operating Expenses | 4.2B | 3.8B | 1.9B | 1.6B | 1.5B |
| Cost and Expenses | 11.9B | 10.3B | 6.7B | 5.5B | 5.0B |
| Operating Income (EBIT) | 680.9M | 355.2M | 1.1B | 940.5M | 746.2M |
| Non-Operating | |||||
| Interest Income | 77.4M | — | — | — | — |
| Interest Expense | 740.5M | 652.0M | 574.3M | 607.8M | 529.5M |
| Net Interest Income | (663.1M) | (652.0M) | (574.3M) | (607.8M) | (529.5M) |
| Other Non-Op Income/Expense | 800.6M | 599.6M | (170.1M) | (576.0M) | (578.4M) |
| Non-Operating Income (excl Interest) | 164.8M | 183.2M | 47.0M | (17.4M) | 43.6M |
| EBT (Pre-Tax Income) | 1.5B | 954.7M | 975.6M | 364.5M | 167.8M |
| Income Tax Expense | 71.0M | (7.1M) | 2.7M | 6.4M | 7.2M |
| Bottom Line | |||||
| Net Income | 1.3B | 936.8M | 951.7M | 340.1M | 141.2M |
| Earnings from Cont. Ops | 1.4B | 961.8M | 972.9M | 358.1M | 160.6M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 1.4B | 944.1M | 953.4M | 339.8M | 141.4M |
| Per Share | |||||
| Basic EPS | $1.93 | $1.41 | $1.58 | $0.66 | $0.31 |
| Diluted EPS | $1.89 | $1.39 | $1.57 | $0.66 | $0.30 |
| Revenue Per Share | $17.90 | $16.03 | $13.02 | $12.56 | $12.50 |
| Shares | |||||
| Basic Shares Outstanding | 704.8M | 665.6M | 603.0M | 515.6M | 462.2M |
| Diluted Shares Outstanding | 732.1M | 679.5M | 608.8M | 518.7M | 465.2M |
| Profitability Metrics | |||||
| EBITDA | 3.0B | 2.3B | 2.8B | 2.4B | 2.0B |
| D&A | 2.5B | 2.1B | 1.7B | 1.4B | 1.3B |
| EBIT | 516.1M | 171.9M | 1.1B | 957.9M | 702.6M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026